5 Ways Insulin Resistance Disrupts the Body Beyond Blood Sugar
Why the same metabolic problem can produce very different clinical patterns
We tend to put insulin resistance into one category, but what’s happening in the body can be very different from one person to another.
One person develops fatty liver while another struggles with reproductive hormones, and someone else has rising blood pressure, elevated triglycerides, or increasing belly fat.
In this episode of ReInvent Healthcare, Dr. Ritamarie explores five major pathways involved in insulin signaling and why different tissues can respond differently to the same hormone.
Understanding what’s happening in these pathways can help practitioners see why the same diagnosis may require a very different approach from one person to the next.
What’s Inside This Episode?
- Why insulin resistance can be different in different tissues
- What happens when muscle becomes less responsive to insulin
- Why the liver can be resistant to some insulin signals but not others
- How fat tissue can release fatty acids even when insulin is high
- The unexpected role insulin plays in blood vessel function
- Why insulin signaling can intersect with reproductive hormones
- Why the same diagnosis doesn’t necessarily mean the same metabolic strategy
If you work with people experiencing insulin resistance, fatty liver, PCOS, hypertension, elevated triglycerides, abdominal weight gain, or other metabolic challenges, this episode will help you understand why there is no single metabolic pattern or one-size-fits-all approach.
Resources and Links:
- Download the full transcript here
- Download the FREE Beyond Protocols: A Practitioner’s Guide to Root-Cause Pattern Recognition
- Explore Metabolic Mastery, our practitioner training program
- Join the Next-Level Health Practitioner Facebook group here for free resources and community support
- Visit INEMethod.com for advanced health practitioner training and tools to elevate your clinical skills and grow your practice by getting life-changing results.
- Check out other podcast episodes here
Transcript
Dr Ritamarie
Why does insulin resistance look so different from one person to another? One person can develop fatty liver, another struggles with reproductive hormone imbalances, and someone else has rising blood pressure, elevated triglycerides, or increased abdominal fat, although most people do have abdominal fat. We give all these people the same label as insulin resistance, but is it really the same thing that’s happening to each one of them?
Not necessarily. Insulin is a signaling hormone and it communicates with different tissues throughout the body, but here’s the fascinating part. Those tissues don’t necessarily become insulin resistant at the same time or to the same degree.
Today we’re going to explore the five major pathways that help explain why insulin resistance can produce such different clinical results, because understanding the pathway may be just as important as recognizing the condition.
Insulin resistance happens when the insulin receptors throughout the body stop hearing the signal of insulin and stop allowing insulin to carry sugar into the blood. Their signaling pathways and the downstream effects of this resistance is different from tissue to tissue.
In most tissues, insulin stimulates glucose uptakes, but in others it regulates glucose production, lipid metabolism, vascular function, and even growth related factors.
Insulin resistance isn’t necessarily one uniform defect throughout the body. In skeletal muscle, it’s supposed to be helping us with glucose disposal, taking the glucose in the blood and using it to activate muscle function. It activates signaling through things called IRS and P13K and AKT.
GLUT-4 transporters inside the cell move towards the cell membrane. Glucose enters the skeletal muscle where it can be used for energy or stored as glycogen. Skeletal muscle is a major destination for glucose after meals, but some things can go wrong.
One is reduced insulin signaling can impair the glucose update. Lipid-derived signaling molecules, inflammation and metabolic stress, can interfere with the action of insulin, and more insulin may be required to achieve a similar glucose response as the cells become resistant. Muscle contraction also stimulates glucose uptake through partly insulin-dependent mechanisms.
There’s one reason physical activity, especially regular muscle contraction, can help improve glucose regulation even before substantial changes in muscle mass occur. Muscle isn’t simply something we want to preserve for strength, and it’s one of our most important metabolic organs, but muscle’s only one piece of the puzzle.
Let’s take a look at the liver. The liver’s another piece, right? Glucose production happens in the liver and lipid metabolism happens in the liver, and normally insulin helps the liver regulate glucose production and storage. It also participates in lipid metabolism.
Lots of things can go wrong with this mechanism. Hepatic insulin resistance can impair suppression of glucose production, and at the same time, hepatic fat synthesis can remain active or increased under certain metabolic conditions.
Excess fatty acid delivery from adipose tissue can further contribute to liver fat accumulation, and liver fat and insulin resistance can reinforce each other. One leads to the other, the other leads back. This introduces the concept of selective insulin resistance. So, to say it simply, insulin resistance doesn’t necessarily turn off every pathway. Some insulin actions become impaired while others stay responsive.
That’s one reason why we see the liver producing too much glucose and why we’re also maybe seeing accumulated excess fat.
Dr Ritamarie (04:46)
Okay, let’s talk about the clinical connection between fatty liver disease and elevated triglycerides and altered glucose regulation.
The liver can be metabolically stressed long before the fasting glucose becomes obviously abnormal. That’s why the standard approach to measuring this stuff doesn’t work very well because so many people fall through the cracks.
Let’s talk about how insulin resistance affects adipose tissue. The normal function is insulin inhibits lipolysis, lipolysis, however you want to say it. You say tomato, I say tomato, but it inhibits that, which is the breakdown of fat and the release of stored fatty acids into circulation after meals.
One mechanism involves three different pathways: AKT, PDE3B, and reduced cyclic AMP, and decreased PKA mediated activation of the lipolytic machinery.
So lots of things can go wrong here.
When adipose tissue becomes resistant to the insulin anti-lipolytic effect, fatty acid release may remain inadequately suppressed, and those fatty acids can reach the liver and the muscle and, of course, build up there. When delivery exceeds appropriate storage and oxidation capacity, those lipid intermediates and ectopic fat can contribute more to insulin signaling and disturbances.
There’s an important paradox here. Someone can have elevated insulin and still have excess fatty acid release, because their adipose tissue isn’t responding appropriately.
Dr Ritamarie (06:29)
This leads to high circulating fatty acids, and when insulin isn’t responding appropriately, and it’s not accomplishing what it’s supposed to accomplish, we end up with a buildup of these fats in the liver. Elevated circulating fatty acids, hepatic steatosis, and broader metabolic dysfunction are what results.
Now let’s move beyond the classic metabolic tissues and look at insulin’s effect on the blood vessels. The muscle, liver, and adipose mechanisms are well described in physiologic research. The real-world metabolic dysfunction reflects interactions across all these tissues rather than a single isolated pathway. What happens with blood vessels? What happens to nitric oxide signaling? These are all affected by insulin resistance.
Normally, insulin acts on vascular endothelial cells through P13K, AKT, and an endothelial nitric oxide synthase, and it supports the production of nitric oxide. Nitric oxide helps blood vessels to relax and plays an important role in vascular health, but when we have vascular insulin resistance, nitric oxide-related signaling may become impaired.
At the same time, other pathways, including MAPK-related signaling, may be relatively preserved, and those changes can contribute to endothelial dysfunction and disturbances in vascular tone.
Additional influences, including inflammation and sympathetic activity, also matter. So, in effect, insulin causes a kind of a stiffening of the vessel walls.
Insulin, we think about it as letting sugar in and letting nutrients in, but it’s not just helping cells manage nutrients. It’s also participating in the regulation of blood flow. This is one of the contributors to vascular dysfunction, and it can be part of an explanation for hypertension.
Let’s look at some hormonal and growth signaling pathways beyond metabolism. Normally, insulin signaling interacts with reproductive hormone pathways, nutrient sensing, and protein metabolism, and cellular growth signaling, but what can go wrong is PCOS. Let’s think about that, or the new name for it, which I can’t keep track of. I’ve been calling it PCOS for decades.
Hyperinsulinemia can amplify ovarian androgen production. We know that, and it can influence hepatic production of sex hormone binding globulin. These changes can contribute to androgen-related symptoms in people who are susceptible, genetically susceptible and past lifestyle
Changes in these pathways that control this are tissue specific, and they shouldn’t be interpreted as proof that insulin resistance caused all hormonal imbalances or growth-related disorders, but it’s important to be considering this because of its effect on androgens and sex hormone binding globulin. Insulin isn’t operating in isolation, it’s communicating with other hormonal and nutrient sensing pathways.
Let’s bring the five pathways together.
Think about what we’ve just covered. In muscle, insulin helps regulate glucose uptake. In the liver, it influences glucose production and lipid metabolism. In adipose tissue, it suppresses the breakdown of fat like lipolysis or lipolysis. In blood vessels, it participates in nitric oxide signaling, and in reproductive and other tissues, it can interact with other hormone pathways.
When someone develops insulin resistance, we shouldn’t assume that every tissue is affected in the same way. It’s not generally, and that helps explain why the clinical picture can vary so dramatically.
The question becomes not just whether somebody is insulin resistant, it’s which physiologic processes may be contributing to the pattern we’re seeing.
That leads to our next important question. If insulin resistance can involve different tissues and pathways, does it make sense to give everyone the same insulin resistance protocol?
Maybe, maybe not, because the same diagnosis doesn’t necessarily mean the same underlying drivers. If you’re a health practitioner, and you’d like to get better at recognizing these patterns, and being able to do personalized nutrition, I invite you to download my free guide, Beyond Protocols, a Practitioner’s Guide to Root Cause Pattern Recognition. The link is in the show notes. It’s a great starting point for moving beyond isolated lab values and one size fits all protocols.
We also have a practitioner training program called Metabolic Mastery. And I invite you to check that out. It’s listed on the show notes. This is what ReInvent Healthcare is about, right? We’re looking at patterns, we’re looking at connections, we’re looking to connect the dots and understand the whole physiology, the whole biochemistry, and help to personalize the approach to care.
If you found this episode valuable, follow the podcast, and like it, and follow it, and share it with another practitioner. This is the future of healthcare, and we all need to be banding together to make sure that everybody gets the unique care that they deserve. Thank you for being on this quest with me. And until next time, shine on.